Lipocine Inc
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
LPCN$1.72+9.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | December 31, | |
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $4,771,758 | $3,148,496 |
| Marketable investment securities | 17,263,788 | 29,381,410 |
| Accrued interest income | 52,254 | 80,427 |
| Contract asset - current portion | - | 579,428 |
| Prepaid and other current assets | 773,424 | 945,319 |
| Total current assets | 22,861,224 | 34,135,080 |
| Contract asset - non-current portion | - | 3,252,500 |
| Property and equipment, net of accumulated depreciation of $1,182,191 and $1,153,530 respectively | 116,095 | 131,589 |
| Other assets | 23,753 | 23,753 |
| Total assets | $23,001,072 | $37,542,922 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $1,395,977 | $600,388 |
| Accrued expenses | 1,218,486 | 1,077,738 |
| Warrant liability - current portion | 17,166 | - |
| Total current liabilities | 2,631,629 | 1,678,126 |
| Warrant liability | - | 229,856 |
| Total liabilities | 2,631,629 | 1,907,982 |
| Commitments and contingencies (notes 8, 9 and 11) | - | - |
| Stockholders’ equity: | ||
| Common stock, par value $0.0001 per share, 200,000,000 shares authorized; 5,316,166 and 5,235,166 issued and 5,315,830 and 5,234,830 outstanding | 8,860 | 8,852 |
| Additional paid-in capital | 220,171,250 | 219,112,164 |
| Treasury stock at cost, 336 shares | (40,712) | (40,712) |
| Accumulated other comprehensive gain (loss) | 7,259 | (20,321) |
| Accumulated deficit | (199,777,214) | (183,425,043) |
| Total stockholders’ equity | 20,369,443 | 35,634,940 |
| Total liabilities and stockholders’ equity | $23,001,072 | $37,542,922 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.